11.90
Finanzdaten der Oric Pharmaceuticals Inc-Aktie (ORIC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
5.78%
34.55
|
36.67 | 39.06 | 32.72 | 39.57 |
| Operating Income/Loss |
5.78%
-34.55
|
-36.67 | -39.06 | -32.72 | -39.57 |
| Nonoperating Income/Loss |
0.93%
4.046
|
4.084 | 2.709 | 2.697 | 3.263 |
| Income/Loss From Continuing Operations Before Tax |
6.39%
-30.50
|
-32.59 | -36.35 | -30.02 | -36.31 |
| Income/Loss From Continuing Operations After Tax |
6.39%
-30.50
|
-32.59 | -36.35 | -30.02 | -36.31 |
|
|
6.39%
-30.50
|
-32.59 | -36.35 | -30.02 | -36.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
94.96%
4.9848
|
98.95 | 78.13 | 71.04 | 0.3103 |
| Diluted Average Shares |
94.96%
4.9848
|
98.95 | 78.13 | 71.04 | 0.3103 |
| Basic Earnings Per Share |
18.18%
-0.27
|
-0.33 | -0.47 | -0.42 | -0.51 |
| Diluted Earnings Per Share |
18.18%
-0.27
|
-0.33 | -0.47 | -0.42 | -0.51 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):